Health

Novo Nordisk Halts Inflammation Drug Trials

Updated 2026-09-07 13:25 UTC 1 source Negative

Novo Nordisk has halted two cardiovascular trials of a drug designed to reduce inflammation, dealing another setback to the approach.

Coverage timeline — 1 article

STAT News

STAT+: Novo Nordisk stops two cardiovascular trials of drug aimed at lowering inflammation

Novo Nordisk has stopped two trials of a drug that aims to tame inflammation as a way to improve cardiovascular health, another blow for the approach.

2026-09-07 11:13 UTC